Immunoassay Market 2025 to 2034
Immunoassay Market 2025 to 2034
Immunoassay Market (By Product: Reagents & Kits, Analyzer, Software and Services; By Technology: ELISA, Rapid Tests, ELISpot, Western Blotting, Radioimmunoassay, Other technologies; By Specimen: Blood, Saliva, Urine, Other Specimen; By Application: Infectious diseases, Endocrinology, Oncology, Bone and mineral disorders, Cardiology, Blood screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Other Application; By End-User: Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies And CRO, Blood Banks, Research & Academic Laboratories, Home Care Setting) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034.
Customisation Request
Revenue, 2025
USD 37.23 Bn
Forecast Year, 2034
USD 56.2
CAGR, 2025 - 2034
4.68%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global Immunoassay market, valued at USD 37.23B in 2025, is projected to reach USD 56.2B by 2034, expanding at a CAGR of 4.68%, driven by growing demand for advanced diagnostic solutions and clinical testing applications.
Immunoassay Market Size Analysis
Immunoassay Market Size By Product 2025 to 2035 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reagents & Kits | 16.80 | 17.17 | 18.22 | 19.46 | 19.88 | 20.97 | 21.38 | 22.65 | 23.39 | 25.32 | 26.57 |
| Analyzer | 13.65 | 14.62 | 15.30 | 15.76 | 16.87 | 17.51 | 18.91 | 19.59 | 20.71 | 21.15 | 21.81 |
| Software and Services | 6.78 | 7.18 | 7.28 | 7.49 | 7.96 | 8.32 | 8.70 | 9.05 | 9.57 | 9.72 | 10.44 |
Immunoassay Market Size By Technology 2025 to 2035 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELISA | 0.08 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 | 0.12 |
| Rapid Tests | 26.03 | 27.22 | 28.79 | 30.31 | 31.57 | 32.85 | 34.46 | 36.03 | 38.00 | 39.94 | 42.20 |
| ELISpot | 1.95 | 1.94 | 2.00 | 2.09 | 2.26 | 2.38 | 2.46 | 2.55 | 2.55 | 2.60 | 2.61 |
| Western Blotting | 4.84 | 5.16 | 5.38 | 5.47 | 5.71 | 6.05 | 6.35 | 6.72 | 7.05 | 7.37 | 7.64 |
| Radioimmunoassay | 3.61 | 3.83 | 3.77 | 3.91 | 4.18 | 4.49 | 4.66 | 4.83 | 4.91 | 5.06 | 5.13 |
| Other technologies | 0.73 | 0.75 | 0.78 | 0.83 | 0.89 | 0.92 | 0.96 | 1.04 | 1.06 | 1.10 | 1.12 |
Immunoassay Market Size By Specimen 2025 to 2035 (USD Billion)
| Specimen | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood | 6.66 | 6.96 | 7.18 | 7.67 | 8.15 | 8.86 | 8.79 | 9.12 | 9.37 | 9.67 | 9.73 |
| Saliva | 2.95 | 3.21 | 3.38 | 3.57 | 3.71 | 4.00 | 4.26 | 4.42 | 4.61 | 4.99 | 5.35 |
| Urine | 16.64 | 17.22 | 18.36 | 19.13 | 19.63 | 20.40 | 21.73 | 22.61 | 23.71 | 24.55 | 26.10 |
| Other Specimen | 10.98 | 11.59 | 11.88 | 12.33 | 13.22 | 13.54 | 14.21 | 15.14 | 16.00 | 16.98 | 17.64 |
Immunoassay Market Size By Application 2025 to 2035 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Infectious diseases | 0.10 | 0.10 | 0.11 | 0.12 | 0.12 | 0.13 | 0.13 | 0.14 | 0.15 | 0.16 | 0.16 |
| Endocrinology | 3.61 | 3.83 | 3.96 | 4.21 | 4.51 | 4.86 | 4.99 | 5.12 | 5.32 | 5.55 | 5.71 |
| Oncology | 4.27 | 4.44 | 4.56 | 4.80 | 4.94 | 5.21 | 5.26 | 5.58 | 5.87 | 6.21 | 6.48 |
| Bone and mineral disorders | 5.45 | 5.70 | 6.04 | 6.36 | 6.72 | 6.92 | 7.24 | 7.45 | 7.83 | 8.15 | 8.65 |
| Cardiology | 2.39 | 2.45 | 2.66 | 2.84 | 2.95 | 3.07 | 3.15 | 3.34 | 3.39 | 3.49 | 3.67 |
| Blood screening | 1.26 | 1.30 | 1.35 | 1.39 | 1.39 | 1.46 | 1.55 | 1.67 | 1.75 | 1.78 | 1.87 |
| Autoimmune Disorders | 2.53 | 2.67 | 2.72 | 2.86 | 3.02 | 3.16 | 3.33 | 3.61 | 3.78 | 3.86 | 4.08 |
| Allergy Diagnostics | 6.30 | 6.49 | 6.65 | 7.02 | 7.37 | 7.59 | 7.95 | 8.24 | 8.90 | 9.68 | 9.97 |
| Toxicology | 4.58 | 4.98 | 5.22 | 5.35 | 5.49 | 5.76 | 6.38 | 6.72 | 6.89 | 7.21 | 7.49 |
| Newborn Screening | 1.77 | 1.87 | 2.02 | 2.10 | 2.18 | 2.28 | 2.34 | 2.41 | 2.55 | 2.60 | 2.73 |
| Other Application | 4.97 | 5.14 | 5.51 | 5.68 | 6.01 | 6.36 | 6.67 | 7.00 | 7.27 | 7.51 | 8.00 |
Immunoassay Market Size By End-User 2025 to 2035 (USD Billion)
| End-User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals & Clinics | 8.29 | 8.96 | 9.44 | 9.93 | 10.17 | 10.39 | 10.87 | 11.21 | 11.50 | 11.96 | 12.91 |
| Clinical Laboratories | 6.45 | 6.71 | 7.06 | 7.37 | 7.63 | 8.05 | 8.50 | 8.83 | 9.35 | 9.76 | 10.15 |
| Pharmaceutical & Biotechnology Companies And Cro | 10.42 | 10.86 | 11.29 | 11.60 | 12.36 | 13.20 | 13.58 | 14.36 | 15.10 | 15.43 | 16.11 |
| Blood Banks | 5.47 | 5.54 | 5.87 | 6.06 | 6.32 | 6.59 | 6.73 | 7.20 | 7.40 | 8.16 | 8.20 |
| Research & Academic Laboratories | 5.86 | 6.15 | 6.36 | 6.94 | 7.36 | 7.67 | 8.36 | 8.71 | 9.34 | 9.85 | 10.37 |
| Home Care Setting | 0.75 | 0.76 | 0.77 | 0.82 | 0.86 | 0.90 | 0.94 | 0.98 | 0.99 | 1.03 | 1.08 |
Immunoassay Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 18.79 | 19.95 | 21.34 | 22.60 | 23.91 | 24.97 | 25.33 | 26.91 | 28.46 | 30.13 | 31.80 |
| Europe | 3.24 | 3.28 | 3.27 | 3.29 | 3.39 | 3.50 | 3.75 | 4.02 | 4.17 | 4.34 | 4.59 |
| Asia-Pacific | 5.55 | 5.78 | 5.93 | 6.32 | 6.71 | 7.08 | 7.62 | 7.83 | 8.37 | 8.39 | 8.78 |
| Latin America | 3.00 | 3.04 | 3.24 | 3.32 | 3.47 | 3.66 | 3.86 | 3.94 | 4.04 | 4.20 | 4.32 |
| The Middle East and Africa | 6.65 | 6.93 | 7.02 | 7.18 | 7.24 | 7.59 | 8.43 | 8.58 | 8.65 | 9.14 | 9.32 |
Immunoassay Market Size to Reach USD 56.2 Billion by 2034
The global Immunoassay market size was estimated at USD 37.23 billion in 2025 and is projected to be worth around USD 56.2 billion by 2034,with a CAGR of 4.68%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
